跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
REKOVELLE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
REKOVELLE
Authorized
STANDARD
REKOVELLE
Ferring Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
9235bb4c58a512ef
Company
Ferring Inc
Type
Standard
Approval Details
Approval Id
9235bb4c58a512ef
Drug Approval Canada Name
REKOVELLE
Product Name
REKOVELLE
Status
Marketed
Status Date
2019-11-01
Original Market Date
2019-11-01
Din
02487470
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Subcutaneous
Schedule
Prescription , Schedule D
Ahfs
68:18.00
Atc Original
G03GA10 FOLLITROPIN DELTA
Atc Name
g 03 ga 10
Aig Number
0160130001
Company Name
Ferring Inc
Company Address
500, 200 Yorkland Blvd, Toronto, Ontario, Canada, M2J 5C1
Active Ingredients
FOLLITROPIN DELTA
36 MCG / 1.08 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
9235bb4c58a512ef
Type
Standard
Back to Health Canada Approvals